Institutions / ACUTA CAPITAL PARTNERS, LLC / Holdings
Back to ACUTA CAPITAL PARTNERS, LLC

Acuta Capital Partners, LLC

All holdings · as of Dec 31, 2025

30 positions

CompanyClassValueShares% of portfolio
Terns Pharmaceuticals, Inc.—$25.74M637,09517.5%
Praxis Precision Medicines, Inc.—$24.47M83,03616.6%
CIDARA THERAPEUTICS INC—$19.69M89,14513.4%
Ocular Therapeutix, Inc—$12.78M1,052,9958.7%
Whitehawk Therapeutics, Inc.WHWKCommon Stock$8.25M3,410,4025.6%
BRIGHT MINDS BIOSCIENCES INC.—$6.59M84,4774.5%
Compass Therapeutics, Inc.—$5.87M1,093,3004.0%
Jazz Pharmaceuticals PLC—$4.93M29,0083.3%
INSMED INC—$4.50M25,8783.1%
ARGEN SE - ADR—$4.08M4,8512.8%
Surrozen, Inc./DESRZNCommon Stock$4.03M178,4152.7%
Amylyx Pharmaceuticals, Inc.—$4.03M333,2582.7%
MINERVA NEUROSCIENCES, INC.—$2.85M709,5001.9%
Tango Therapeutics, Inc.—$2.51M282,7321.7%
Taysha Gene Therapies, Inc.TSHACommon Stock$2.50M454,8271.7%
ZYMEWORKS INC.—$2.11M80,1431.4%
Oculis Holding AG—$2.03M101,7771.4%
Design Therapeutics, Inc.DSGNCommon Stock$1.42M150,9061.0%
Inhibrx Biosciences, Inc.—$1.29M16,3770.9%
United Therapeutics Corp—$1.12M2,2960.8%
Verastem, Inc.—$1.11M143,4460.8%
Maze Therapeutics, Inc.—$828.6K20,0000.6%
MoonLake ImmunotherapeuticsMLTXCommon Stock$781.3K59,2800.5%
Sutro Biopharma, Inc.—$780.4K67,4510.5%
Dianthus Therapeutics, Inc.—$688.5K16,7080.5%
Revolution Medicines, Inc.—$669.9K8,4110.5%
LB PHARMACEUTICALS INCLBRXCommon Stock$667.8K30,0000.5%
Pasithea Therapeutics Corp.KTTACommon Stock$580.5K450,0000.4%
Unicycive Therapeutics, Inc.—$346.1K59,9850.2%
NUVATION BIO INC -CW27—$30.0K90,8320.0%
← PrevPage 1 of 1Next →